Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Follow-up in gastrointestinal cancer

Follow-up in gastrointestinal cancer Follow-up after curative treatment of patients with gastrointestinal cancers aims to detect recurrent disease and to provide curative treatment to prolong overall survival if possible. This, however, has only been shown for colorectal cancers. Regular visits including testing of carcinoembryonic antigen and appropriate staging has been shown to enable curative treatment even in relapse. For other gastrointestinal cancers, positive effects of regular follow-up visits on survival have not been shown so far. This is mostly also due to lacking curative treatment strategies in case of relapse. In these cases, follow-up is recommended for providing palliative treatment, detecting recurrence for quality issues, treating complications or symptoms due to relapse, and providing psychological support. This review will give a brief overview about the current follow-up issues in colorectal, esophagogastric, and pancreatic cancers, as these are clinically the most relevant. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Follow-up in gastrointestinal cancer

Download PDF
5 pages

Loading next page...
 
/lp/springer-journals/follow-up-in-gastrointestinal-cancer-SZjtsVqpxS
Publisher
Springer Journals
Copyright
Copyright © 2014 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-014-0152-x
Publisher site
See Article on Publisher Site

Abstract

Follow-up after curative treatment of patients with gastrointestinal cancers aims to detect recurrent disease and to provide curative treatment to prolong overall survival if possible. This, however, has only been shown for colorectal cancers. Regular visits including testing of carcinoembryonic antigen and appropriate staging has been shown to enable curative treatment even in relapse. For other gastrointestinal cancers, positive effects of regular follow-up visits on survival have not been shown so far. This is mostly also due to lacking curative treatment strategies in case of relapse. In these cases, follow-up is recommended for providing palliative treatment, detecting recurrence for quality issues, treating complications or symptoms due to relapse, and providing psychological support. This review will give a brief overview about the current follow-up issues in colorectal, esophagogastric, and pancreatic cancers, as these are clinically the most relevant.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Jun 27, 2014

References

  • The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study
    Enbald, P; Adami, HA; Glimelius, B
  • Cumulative incidence of metachronous colorectal cancer
    Cali, RL; Pitsch, RM; Thorson, AG
  • Long-term results of surgical therapy of colon cancer. Results of the colorectal cancer study group
    Hermanek, P,; Wiebelt, H; Riedl, S; Staimmer, D; Hermanek, P.
  • What is the risk factor for metachronous colorectal carcinoma?
    Yamazaki, T; Takii, Y; Okamoto, H; Sakai, Y; Hatakeyama, K.
  • Second primary cancers after sporadic and familial colorectal cancer
    Hemminki, K; Li, X; Dong, C.
  • Risk factors of local recurrence of colorectal cancer: a multivariate study
    Pietra, N; Sarli, L; Thenasseril, BJ; Costi, R; Sansebastiano, G; Peracchia, A.
  • Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto, S; Akasu, T; Fujita, S; Moriya Yamamoto, S; Akasu, T; Fujita, S; Moriya, Y.
  • Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis?
    Colibaseanu, DT; Mathis, KL; Abdelsattar, ZM; Larson, DW; Haddock, MG; Dozois, EJ.
  • Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors
    Kanas, GP; Taylor, A; Primrose, JN
  • Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis
    Gonzalez, M; Poncet, A; Combescure, C; Robert, J; Ris, HB; Gervaz, P.
  • Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial
  • Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto, S; Akasu, T; Fujita, S
  • Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance
    Körner, H; Søreide, K; Stokkeland, PJ
  • The clinical significance of invasion of veins by rectal cancer
    Talbot, IC; Ritchie, S; Leighton, MH
  • Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion
    Minsky, BD; Mies, C; Recht, A
  • Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance
    Krasna, MJ; Flancbaum, L; Cody, RP; Shneibaum, S; Ari, GB.
  • Vascular invasion of colorectal carcinoma readily visible with certain stains
    Inoue, T; Mori, M; Shimono, R
  • Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089
    Green, RJ; Metlay, JP; Propert, K
  • Factors affecting local recurrence of colonic adenocarcinoma
    Harris, GJ; Church, JM; Senagore, AJ
  • Late locoregional recurrence in rectal carcinoma
    Merkel, S; Meyer, T; Gohl, J; Hohenberger, W.
  • Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma
    Poulin, EC; Schlachta, CM; Gregoire, R
  • Recurrence and survival after mesorectal excision for rectal cancer
    Bulow, S; Christensen, IJ; Harling, H
  • Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients
    Schoemaker, D; Black, R; Giles, L; Toouli, J.
  • Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial
    Secco, GB; Fardelli, R; Gianquinto, D
  • Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial
    Rodriguez-Moranta, F; Salo, J; Arcusa, A
  • Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study
    Pietra, N; Sarli, L; Costi, R; Ouchemi, C; Grattarola, M; Peracchia, A.
  • Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up
    Ohlsson, B; Breland, U; Ekberg, H; Graffner, H; Tranberg, KG.
  • A prospective randomized study of follow-up after radical surgery for colorectal cancer
    Kjeldsen, BJ; Kronborg, O; Fenger, C; Jorgensen, OD.
  • Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial
    Makela, JT; Laitinen, SO; Kairaluoma, MI.
  • Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
    Renehan, AG; Egger, M; Saunders, MP; O’Dwyer, ST.
  • Follow-up of patients with colorectal cancer. A meta-analysis
    Bruinvels, DJ; Stiggelbout, AM; Kievit, J; Houwelingen, HC; Habbema, JD; Velde, CJ.
  • An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
    Moertel, CG; Fleming, TR; MacDonald, JS; Haller, DG; Laurie, JA; Tangen, C
  • The value of follow-up after curative surgery of colorectal carcinoma
    Safi, F; Beyer, HG.
  • Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients
    Zeng, Z; Cohen, AM; Urmacher, C.
  • A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review
    Cardoso, R; Coburn, NG; Seevaratnam, R
  • Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
    Stahl, M; Mariette, C; Haustermans, K
  • Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
    Waddell, T; Verheij, M; Allum, W
  • Surveillance of pancreatic cancer patients after surgical resection
    Sheffield, KM; Crowell, KT; Lin, YL
  • Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study
    Witkowski, ER; Smith, JK; Ragulin-Coyne, E
  • Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings
    Hishinuma, S; Ogata, Y; Tomikawa, M
  • Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy
    Tzeng, CW; Fleming, JB; Lee, JE
  • Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival
    Nordby, T; Hugenschmidt, H; Fagerland, MW
  • Üancreatic adenocarcinoma: ESMO–ESDO clinical practice guidelines for diagnosis, treatment and follow-up
    Seufferlein, T; Bachet, JB; Van Cutsem, E